10:32 AM EST - Willow Biosciences Inc. : Announces execution of a Master Services Agreement with an innovative biotech company focused on age-related diseases. Through this partnership, Willow will develop precision fermentation processes for a class of molecules with targets being developed as nutritional supplements for health and wellness and active pharmaceutical ingredients. Willow Biosciences Inc.
shares T.WLLW are trading up $0.01 at $0.13.
